These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37169632)

  • 1. Using the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction.
    Dunlop J; Potpara T; Lip GYH
    Eur J Intern Med; 2023 Jul; 113():20-21. PubMed ID: 37169632
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic implications of the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction.
    Luo J; Li Z; Qin X; Zhang X; Liu X; Zhang W; Xu W; Zhang Y; Fang Y; Liu B; Wei Y;
    Eur J Intern Med; 2023 Jul; 113():38-44. PubMed ID: 37037721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
    Chao TF; Tse HF; Teo WS; Park HW; Shimizu W; Chen SA; Lip GYH;
    Eur J Clin Invest; 2022 Oct; 52(10):e13825. PubMed ID: 35700114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients.
    Guo Y; Imberti JF; Kotalczyk A; Wang Y; Lip GYH;
    Eur J Clin Invest; 2022 Jun; 52(6):e13751. PubMed ID: 35080269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study.
    Bretler DM; Hansen PR; Lindhardsen J; Ahlehoff O; Andersson C; Jensen TB; Raunsø J; Torp-Pedersen C; Gislason GH
    PLoS One; 2012; 7(12):e51580. PubMed ID: 23284717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-onset atrial fibrillation predicts malignant arrhythmias in post-myocardial infarction patients--a Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy.
    Ruwald AC; Bloch Thomsen PE; Gang U; Jørgensen RM; Huikuri HV; Jons C
    Am Heart J; 2013 Nov; 166(5):855-63.e3. PubMed ID: 24176441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry.
    Ding WY; Proietti M; Boriani G; Fauchier L; Blomström-Lundqvist C; Marin F; Potpara TS; Lip GYH;
    Europace; 2022 May; 24(5):721-728. PubMed ID: 35446354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry).
    Parashar S; Kella D; Reid KJ; Spertus JA; Tang F; Langberg J; Vaccarino V; Kontos MC; Lopes RD; Lloyd MS
    Am J Cardiol; 2013 Nov; 112(9):1390-5. PubMed ID: 24135301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation increases the risk of new-onset myocardial infarction amongst working-age population: a propensity-matched study.
    Yue B; Hou Q; Bredehorst J; Han Q; Zhang B; Zhang C; Zhang J; Chen S; Wu S; Li K
    Herz; 2023 Oct; 48(5):408-412. PubMed ID: 37264124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of atrial fibrillation in acute coronary syndromes: results from the ARIAM registry.
    Almendro-Delia M; Valle-Caballero MJ; Garcia-Rubira JC; Muñoz-Calero B; Garcia-Alcantara A; Reina-Toral A; Benítez-Parejo J; Hidalgo-Urbano R;
    Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):141-8. PubMed ID: 24381097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort.
    Malavasi VL; Vitolo M; Colella J; Montagnolo F; Mantovani M; Proietti M; Potpara TS; Lip GYH; Boriani G
    Intern Emerg Med; 2022 Jun; 17(4):1001-1012. PubMed ID: 34855117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry.
    Rivera-Caravaca JM; Piot O; Roldán-Rabadán I; Denis A; Anguita M; Mansourati J; Pérez-Cabeza A; Marijon E; García-Seara J; Leclercq C; García-Bolao I; Lellouche N; Potpara T; Boriani G; Fauchier L; Lip GYH; Marín F
    Europace; 2022 Feb; 24(2):202-210. PubMed ID: 34374759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    Lee CJ; Pallisgaard JL; Olesen JB; Carlson N; Lamberts M; Gislason GH; Torp-Pedersen C; Brandes A; Husted SE; Johnsen SP; Hansen ML
    J Am Coll Cardiol; 2017 Jun; 69(24):2901-2909. PubMed ID: 28619189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.
    Bang CN; Gislason GH; Greve AM; Bang CA; Lilja A; Torp-Pedersen C; Andersen PK; Køber L; Devereux RB; Wachtell K
    J Am Heart Assoc; 2014 Jan; 3(1):e000382. PubMed ID: 24449803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation is an independent risk factor for new-onset myocardial infarction: a prospective study.
    Wu J; Hou Q; Han Q; Mao R; Yue B; Yu J; Chen S; Wu S; Li K
    Acta Cardiol; 2023 May; 78(3):341-348. PubMed ID: 36251263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines.
    Vora AN; Wang TY; Li S; Chiswell K; Hess C; Lopes RD; Rao SV; Peterson ED
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study.
    Artola Arita V; Van De Lande ME; Khalilian Ekrami N; Nguyen BO; Van Melle JM; Geelhoed B; De With RR; Weberndörfer V; Erküner Ö; Hillege H; Linz D; Ten Cate H; Spronk HMH; Koldenhof T; Tieleman RG; Schotten U; Crijns HJGM; Van Gelder IC; Rienstra M
    Europace; 2023 Apr; 25(4):1323-1331. PubMed ID: 36857318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
    Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K
    Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of chronic kidney disease and atrial fibrillation on morbidity and mortality in patients with acute myocardial infarction.
    Hwang HS; Park MW; Yoon HE; Chang YK; Yang CW; Kim SY; Cho JS; Kim CJ; Park GM; Park CS; Choi YS; Koh YS; Lee JM; Shin DI; Seo SM; Jeon DS; Moon KW; Yoo KD; Kim HY; Kim DB; Park HJ; Kim PJ; Chang K; Chung WS; Seung KB; Jeong MH; Her SH; Ahn Y
    Am J Nephrol; 2014; 40(4):345-52. PubMed ID: 25358406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction.
    Batra G; Lindhagen L; Andell P; Erlinge D; James S; Spaak J; Oldgren J
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.